ISTH DIC subcommittee communication on anticoagulation in COVID-19.
Publication
, Journal Article
Thachil, J; Juffermans, NP; Ranucci, M; Connors, JM; Warkentin, TE; Ortel, TL; Levi, M; Iba, T; Levy, JH
Published in: J Thromb Haemost
September 2020
Hypercoagulability is an increasingly recognized complication of SARS-CoV-2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID-19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special patient populations, including those with high body mass index and renal impairment, require special consideration. Although the current evidence is still insufficient, we provide a pragmatic approach to anticoagulation in COVID-19, but stress the need for further trials in this area.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Thromb Haemost
DOI
EISSN
1538-7836
Publication Date
September 2020
Volume
18
Issue
9
Start / End Page
2138 / 2144
Location
England
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Risk Factors
- Pneumonia, Viral
- Patient Selection
- Pandemics
- Humans
- Host-Pathogen Interactions
- Coronavirus Infections
- Clinical Decision-Making
Citation
APA
Chicago
ICMJE
MLA
NLM
Thachil, J., Juffermans, N. P., Ranucci, M., Connors, J. M., Warkentin, T. E., Ortel, T. L., … Levy, J. H. (2020). ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemost, 18(9), 2138–2144. https://doi.org/10.1111/jth.15004
Thachil, Jecko, Nicole P. Juffermans, Marco Ranucci, Jean M. Connors, Theodore E. Warkentin, Thomas L. Ortel, Marcel Levi, Toshiaki Iba, and Jerrold H. Levy. “ISTH DIC subcommittee communication on anticoagulation in COVID-19.” J Thromb Haemost 18, no. 9 (September 2020): 2138–44. https://doi.org/10.1111/jth.15004.
Thachil J, Juffermans NP, Ranucci M, Connors JM, Warkentin TE, Ortel TL, et al. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemost. 2020 Sep;18(9):2138–44.
Thachil, Jecko, et al. “ISTH DIC subcommittee communication on anticoagulation in COVID-19.” J Thromb Haemost, vol. 18, no. 9, Sept. 2020, pp. 2138–44. Pubmed, doi:10.1111/jth.15004.
Thachil J, Juffermans NP, Ranucci M, Connors JM, Warkentin TE, Ortel TL, Levi M, Iba T, Levy JH. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J Thromb Haemost. 2020 Sep;18(9):2138–2144.
Published In
J Thromb Haemost
DOI
EISSN
1538-7836
Publication Date
September 2020
Volume
18
Issue
9
Start / End Page
2138 / 2144
Location
England
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Risk Factors
- Pneumonia, Viral
- Patient Selection
- Pandemics
- Humans
- Host-Pathogen Interactions
- Coronavirus Infections
- Clinical Decision-Making